Literature DB >> 11723767

Are antineutrophil cytoplasmic antibody-associated vasculitides pauci-immune?

R H Brons1, C G Kallenberg, J W Tervaert.   

Abstract

The role of ICs in ANCA-associated vasculitides remains controversial. The ANCA-associated vasculitides are described as being pauci-immune. We hypothesize that the absence of ICs is a result of an exaggerated inflammatory response caused by the presence of ANCAs. We present evidence indicating that ICs may play a role in the initiation or relapses of the disease. The nature of the involved antigen(s) is not yet known. Possible candidates are reviewed and include ANCA antigens, AECA antigens, and staphylococcal antigens.

Mesh:

Substances:

Year:  2001        PMID: 11723767     DOI: 10.1016/s0889-857x(05)70238-6

Source DB:  PubMed          Journal:  Rheum Dis Clin North Am        ISSN: 0889-857X            Impact factor:   2.670


  4 in total

Review 1.  [Rapidly progressive glomerulonephritis:classification, pathogenesis and clinical management].

Authors:  R Birck; F J Van Der Woude
Journal:  Internist (Berl)       Date:  2003-09       Impact factor: 0.743

2.  MPO-ANCA crescentic glomerulonephritis complicated by membranous nephropathy: MPO demonstrated in epimembranous deposits.

Authors:  Kei Matsumoto; Hirokazu Honda; Takanori Shibata; Daisuke Sanada; Yukihiro Wada; Eijin Ashikaga; Aki Kuroki; Kozo Kitazawa; Tadao Akizawa
Journal:  NDT Plus       Date:  2009-08-24

3.  Long-Term Renal Survival in Antineutrophil Cytoplasmic Antibody-Associated Glomerulonephritis With Complement C3 Deposition.

Authors:  Rina Oba; Go Kanzaki; Takaya Sasaki; Yusuke Okabayashi; Kotaro Haruhara; Masahiro Okabe; Shinya Yokote; Kentaro Koike; Keita Hirano; Hideo Okonogi; Nobuo Tsuboi; Takashi Yokoo
Journal:  Kidney Int Rep       Date:  2021-08-12

4.  Direct immunofluorescence in cutaneous vasculitis: experience from a referral hospital in India.

Authors:  Bn Nandeesh; Rajalakshmi Tirumalae
Journal:  Indian J Dermatol       Date:  2013-01       Impact factor: 1.494

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.